Growing community of inventors

Gyeonggi-do, South Korea

Hyeong Joon Lim

Average Co-Inventor Count = 4.99

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 1

Hyeong Joon LimYang Je Cho (2 patents)Hyeong Joon LimJin Wook Jang (2 patents)Hyeong Joon LimYoung In Kim (1 patent)Hyeong Joon LimDoo Sik Kim (1 patent)Hyeong Joon LimWon Il Yoo (1 patent)Hyeong Joon LimJee Young Kim (1 patent)Hyeong Joon LimMyoung Hwan Kim (1 patent)Hyeong Joon LimKyung Sul Kim (1 patent)Hyeong Joon LimTaek Joo Lim (1 patent)Hyeong Joon LimKyoung Chul Ko (1 patent)Hyeong Joon LimOh Woong Kwon (1 patent)Hyeong Joon LimEun Young Park (1 patent)Hyeong Joon LimYoo Seok Kim (1 patent)Hyeong Joon LimHyeong Joon Lim (3 patents)Yang Je ChoYang Je Cho (8 patents)Jin Wook JangJin Wook Jang (5 patents)Young In KimYoung In Kim (63 patents)Doo Sik KimDoo Sik Kim (4 patents)Won Il YooWon Il Yoo (3 patents)Jee Young KimJee Young Kim (2 patents)Myoung Hwan KimMyoung Hwan Kim (2 patents)Kyung Sul KimKyung Sul Kim (1 patent)Taek Joo LimTaek Joo Lim (1 patent)Kyoung Chul KoKyoung Chul Ko (1 patent)Oh Woong KwonOh Woong Kwon (1 patent)Eun Young ParkEun Young Park (1 patent)Yoo Seok KimYoo Seok Kim (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Eyegene Inc. (2 from 11 patents)

2. Eyebio Korea (1 from 4 patents)


3 patents:

1. 12428446 - Peptide compound or pharmaceutically acceptable salt thereof

2. 9290542 - Pharmaceutical composition for preventing or treating arteriosclerosis

3. 8372811 - Composition for treating retinopathy or glaucoma comprising thrombin derived peptides

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/8/2025
Loading…